Discover
AI-synthesized health news from 21+ trusted publications
Stories Today
11
Outlets
21+
Avg Confidence
86%
Status
Live
Each article is automatically synthesized from multiple real-world publications. Sources are scored for trust and novelty — we track who originates vs. who rewrites.
Updated 07:51 PM
GLP-1 Drugs Show Unexpected Cardiovascular Benefits Beyond Weight Loss
A wave of new research confirms that GLP-1 receptor agonists like semaglutide and tirzepatide significantly reduce cardiovascular events independent of weight loss. The SELECT trial's extended follow-up data shows a 20% reduction in major adverse cardiac events across multiple patient populations.
Semaglutide and Cardiovascular Outcomes in Patients with Obesity
Novo Nordisk's Wegovy shows heart benefits that go beyond weight loss
GLP-1 receptor agonists: cardiovascular mechanisms beyond metabolic effects
Weight loss drugs like Wegovy may protect your heart, major study finds
GLP-1 Medications: New Heart Benefits Discovered
NeurologyAI Blood Test Detects Alzheimer's 15 Years Before Symptoms with 92% Accuracy
Researchers have developed an AI-powered blood test that identifies Alzheimer's-related biomarkers up to 15 years before clinical symptoms appear. The test analyzes a panel of plasma proteins using machine learning, achieving diagnostic accuracy comparable to PET scans at a fraction of the cost.
Mental HealthGut Microbiome Transplants Show Promise for Treatment-Resistant Depression
A Phase II clinical trial demonstrates that fecal microbiota transplantation from carefully selected donors led to significant improvement in patients with treatment-resistant depression. Specific bacterial strains correlate with improved mood outcomes.
FDA Approves Second CRISPR Therapy for Sickle Cell, Expanding Access
The FDA has approved a second CRISPR-based gene therapy for sickle cell disease using a novel base-editing approach that doesn't require cutting DNA. The approval is expected to significantly expand access, priced 40% lower than the first approved treatment.
Large-Scale Rapamycin Trial Shows 8% Increase in Healthy Lifespan Markers
The first large-scale randomized controlled trial of low-dose rapamycin in healthy adults over 60 reports improved immune function, reduced inflammatory markers, and an 8% improvement in composite healthy aging scores over 18 months.
OncologyMulti-Cancer Liquid Biopsy Detects 14 Cancer Types from Single Blood Draw
A new multi-cancer early detection test identifies signals from 14 different cancer types using a single blood draw. The PATHFINDER-2 study shows 83% specificity with a positive predictive value of 44%.
Growing Evidence Links GLP-1 Drugs to Reduced Addiction and Compulsive Behaviors
An accumulating body of research suggests GLP-1 receptor agonists may have unexpected effects on addiction pathways. Multiple observational studies indicate reduced alcohol consumption, smoking cessation, and decreased compulsive gambling among patients taking semaglutide.
Meta-Analysis Confirms Vitamin D Supplementation Reduces Respiratory Infections by 12%
A comprehensive meta-analysis of 46 RCTs involving over 75,000 participants confirms that vitamin D supplementation provides a modest but significant reduction in acute respiratory tract infections, with the greatest benefit in those with baseline deficiency.
Continuous Glucose Monitors for Non-Diabetics: What the Latest Research Actually Shows
As CGM devices become popular among health-conscious consumers without diabetes, researchers examine whether the data actually leads to better outcomes. A new systematic review finds mixed evidence — benefits for awareness but limited proof of long-term metabolic improvement.
MDMA-Assisted Therapy Receives Breakthrough Designation for PTSD Treatment
Following Phase III trial results showing 71% of participants no longer meeting PTSD diagnostic criteria after three sessions, the FDA has granted breakthrough therapy designation to MDMA-assisted psychotherapy, paving the way for potential approval by late 2026.
Universal Flu Vaccine Enters Phase III with Broad Protection Across All Strains
A single-dose nanoparticle vaccine targeting conserved influenza proteins provides protection against all known flu strains in a 3,200-participant trial, potentially eliminating the need for annual flu shots.
Trending Outlets
PubMed
156 articles this week
bioRxiv
142 articles this week
Science Daily
83 articles this week
Healthline
71 articles this week
WebMD
65 articles this week
STAT News
62 articles this week
Medical News Today
58 articles this week
CNN Health
54 articles this week
How OneME Synthesizes
Scan — Monitor 500+ health & medical publications 24/7
Cluster — AI groups articles covering the same story
Synthesize — Write one comprehensive article citing all sources
Score — Calculate confidence from source quality & consensus
Verify — AI checks for novelty — did they steal or originate?
Provider Spotlights
Quick Links
Discover
AI-synthesized health news from 21+ trusted publications
Stories Today
11
Outlets
21+
Avg Confidence
86%
Status
Live
Each article is automatically synthesized from multiple real-world publications. Sources are scored for trust and novelty — we track who originates vs. who rewrites.
Updated 07:51 PMGLP-1 Drugs Show Unexpected Cardiovascular Benefits Beyond Weight Loss
A wave of new research confirms that GLP-1 receptor agonists like semaglutide and tirzepatide significantly reduce cardiovascular events independent of weight loss. The SELECT trial's extended follow-up data shows a 20% reduction in major adverse cardiac events across multiple patient populations.
Semaglutide and Cardiovascular Outcomes in Patients with Obesity
Novo Nordisk's Wegovy shows heart benefits that go beyond weight loss
GLP-1 receptor agonists: cardiovascular mechanisms beyond metabolic effects
Weight loss drugs like Wegovy may protect your heart, major study finds
GLP-1 Medications: New Heart Benefits Discovered
NeurologyAI Blood Test Detects Alzheimer's 15 Years Before Symptoms with 92% Accuracy
Researchers have developed an AI-powered blood test that identifies Alzheimer's-related biomarkers up to 15 years before clinical symptoms appear. The test analyzes a panel of plasma proteins using machine learning, achieving diagnostic accuracy comparable to PET scans at a fraction of the cost.
Mental HealthGut Microbiome Transplants Show Promise for Treatment-Resistant Depression
A Phase II clinical trial demonstrates that fecal microbiota transplantation from carefully selected donors led to significant improvement in patients with treatment-resistant depression. Specific bacterial strains correlate with improved mood outcomes.
FDA Approves Second CRISPR Therapy for Sickle Cell, Expanding Access
The FDA has approved a second CRISPR-based gene therapy for sickle cell disease using a novel base-editing approach that doesn't require cutting DNA. The approval is expected to significantly expand access, priced 40% lower than the first approved treatment.
Large-Scale Rapamycin Trial Shows 8% Increase in Healthy Lifespan Markers
The first large-scale randomized controlled trial of low-dose rapamycin in healthy adults over 60 reports improved immune function, reduced inflammatory markers, and an 8% improvement in composite healthy aging scores over 18 months.
OncologyMulti-Cancer Liquid Biopsy Detects 14 Cancer Types from Single Blood Draw
A new multi-cancer early detection test identifies signals from 14 different cancer types using a single blood draw. The PATHFINDER-2 study shows 83% specificity with a positive predictive value of 44%.
Growing Evidence Links GLP-1 Drugs to Reduced Addiction and Compulsive Behaviors
An accumulating body of research suggests GLP-1 receptor agonists may have unexpected effects on addiction pathways. Multiple observational studies indicate reduced alcohol consumption, smoking cessation, and decreased compulsive gambling among patients taking semaglutide.
Meta-Analysis Confirms Vitamin D Supplementation Reduces Respiratory Infections by 12%
A comprehensive meta-analysis of 46 RCTs involving over 75,000 participants confirms that vitamin D supplementation provides a modest but significant reduction in acute respiratory tract infections, with the greatest benefit in those with baseline deficiency.
Continuous Glucose Monitors for Non-Diabetics: What the Latest Research Actually Shows
As CGM devices become popular among health-conscious consumers without diabetes, researchers examine whether the data actually leads to better outcomes. A new systematic review finds mixed evidence — benefits for awareness but limited proof of long-term metabolic improvement.
MDMA-Assisted Therapy Receives Breakthrough Designation for PTSD Treatment
Following Phase III trial results showing 71% of participants no longer meeting PTSD diagnostic criteria after three sessions, the FDA has granted breakthrough therapy designation to MDMA-assisted psychotherapy, paving the way for potential approval by late 2026.
Universal Flu Vaccine Enters Phase III with Broad Protection Across All Strains
A single-dose nanoparticle vaccine targeting conserved influenza proteins provides protection against all known flu strains in a 3,200-participant trial, potentially eliminating the need for annual flu shots.
Trending Outlets
PubMed
156 articles this week
bioRxiv
142 articles this week
Science Daily
83 articles this week
Healthline
71 articles this week
WebMD
65 articles this week
STAT News
62 articles this week
Medical News Today
58 articles this week
CNN Health
54 articles this week
How OneME Synthesizes
Scan — Monitor 500+ health & medical publications 24/7
Cluster — AI groups articles covering the same story
Synthesize — Write one comprehensive article citing all sources
Score — Calculate confidence from source quality & consensus
Verify — AI checks for novelty — did they steal or originate?